Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 571 AL 585

Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease

Morroni F, Sita G, Djemil A, D'Amico M, Pruccoli L, Cantelli-Forti G, Hrelia P, Tarozzi A.

J Agric Food Chem. 2018 Jan 31;66(4):856-865. doi: 10.1021/acs.jafc.7b04641. Epub 2018 Jan 22.

Palliative care for Parkinson's disease

Ng JSC.

Ann Palliat Med. 2018 Jul;7(3):296-303. doi: 10.21037/apm.2017.12.02. Epub 2018 Jan 4.

Practical considerations in medical cannabis administration and dosing

MacCallum CA, Russo EB.

Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4.

The LRRK2 signalling system

Price A, Manzoni C, Cookson MR, Lewis PA.

Cell Tissue Res. 2018 Jul;373(1):39-50. doi: 10.1007/s00441-017-2759-9. Epub 2018 Jan 8.

Automated Mechanical Peripheral Stimulation Improves Gait Parameters in Subjects With Parkinson Disease and Freezing of Gait: A Randomized Clinical Trial

Pinto C, Pagnussat AS, Rozin Kleiner AF, Marchese RR, Salazar AP, Rieder CRM, Galli M.

Am J Phys Med Rehabil. 2018 Jun;97(6):383-389. doi: 10.1097/PHM.0000000000000890.

Towards stem cell based therapies for Parkinson's disease

Parmar M.

Development. 2018 Jan 8;145(1):dev156117. doi: 10.1242/dev.156117.

Neurotoxins as Preclinical Models for Parkinson's Disease

Segura-Aguilar J.

Neurotox Res. 2018 Nov;34(4):870-877. doi: 10.1007/s12640-017-9856-0. Epub 2018 Jan 8.

Goal-orientated cognitive rehabilitation for dementias associated with Parkinson's disease-A pilot randomised controlled trial

Hindle JV, Watermeyer TJ, Roberts J, Brand A, Hoare Z, Martyr A, Clare L.

Int J Geriatr Psychiatry. 2018 May;33(5):718-728. doi: 10.1002/gps.4845. Epub 2018 Jan 4.

Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications

El Harrad L, Bourais I, Mohammadi H, Amine A.

Sensors (Basel). 2018 Jan 9;18(1):164. doi: 10.3390/s18010164.

200 Years of Parkinson's disease: what have we learnt from James Parkinson?

McDonald C, Gordon G, Hand A, Walker RW, Fisher JM.

Age Ageing. 2018 Mar 1;47(2):209-214. doi: 10.1093/ageing/afx196.

The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease

Gao Y, Wilson GR, Stephenson SEM, Bozaoglu K, Farrer MJ, Lockhart PJ.

Mov Disord. 2018 Feb;33(2):196-207. doi: 10.1002/mds.27270. Epub 2018 Jan 9.

Presynaptic endocytic factors in autophagy and neurodegeneration

Azarnia Tehran D, Kuijpers M, Haucke V.

Curr Opin Neurobiol. 2018 Feb;48:153-159. doi: 10.1016/j.conb.2017.12.018. Epub 2018 Jan 6.

Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease

Song N, Wang J, Jiang H, Xie J.

Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):967-973. doi: 10.1016/j.bbadis.2018.01.008. Epub 2018 Jan 6.

Falls in Cognitively Impaired Older Adults: Implications for Risk Assessment And Prevention

Montero-Odasso M, Speechley M.

J Am Geriatr Soc. 2018 Feb;66(2):367-375. doi: 10.1111/jgs.15219. Epub 2018 Jan 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias